Bilateral Meetings
- Thursday (1:30pm – 6:00pm)
- Friday (9:00am – 12:00pm)
DescriptionThe Ofichem-group performs several activities.
First, the production, development and distribution of active pharmaceutical ingredients (API’s). The production is performed in a EU-GMP and FDA certified manufacturing facility. Development goes from early stage medicinal chemistry and chemical route synthesis discovery, to the production of non-GMP preclinical material, to the GMP production of material for clinical phase 1 up to phase 3 and finally to commercial production.
In addition, other activities are performed such as extern quality control (QC) analysis, analytical validation studies, stability studies, etc of both API’s and finished dosage forms. Audit services of API suppliers, predominantly in the far east, are performed by another business unit.
The last aspect concerns the production of finished dosage forms (medicines) for niche products.
Despite the fact that we work under a very strict quality regime (GMP according EU-GMP and FDA), we are still a very flexible, proactive and dynamic company. The wishes of the customer are leading in the development.
We have more than 700 customers in more than 70 countries worldwide. Predominantly EU and USA. Most of the big- and medium sized pharmaceutical companies.
First, the production, development and distribution of active pharmaceutical ingredients (API’s). The production is performed in a EU-GMP and FDA certified manufacturing facility. Development goes from early stage medicinal chemistry and chemical route synthesis discovery, to the production of non-GMP preclinical material, to the GMP production of material for clinical phase 1 up to phase 3 and finally to commercial production.
In addition, other activities are performed such as extern quality control (QC) analysis, analytical validation studies, stability studies, etc of both API’s and finished dosage forms. Audit services of API suppliers, predominantly in the far east, are performed by another business unit.
The last aspect concerns the production of finished dosage forms (medicines) for niche products.
Despite the fact that we work under a very strict quality regime (GMP according EU-GMP and FDA), we are still a very flexible, proactive and dynamic company. The wishes of the customer are leading in the development.
We have more than 700 customers in more than 70 countries worldwide. Predominantly EU and USA. Most of the big- and medium sized pharmaceutical companies.
Organization Type
Company
Organization Size51-100
Founding Year1975
Phone0031 599 583433
Email molema@ofichem.com
CountryNetherlands
CityTer Apel, Heembadweg 5 Google map
Development and manufacture of Active Pharmaceutical Ingredients (API's)
We would like to meet with small and medium sized pharmaceutical companies and start-up (biotech) companies that have the ambition to bring a new medicine to the market and that are in a need for a developer and manufacture of their active pharmaceutical ingredient.
Cooperation Offered
- Technical co-operation
- Outsourcing co-operation